Equities
  • Price (EUR)4.34
  • Today's Change4.34 / --
  • Shares traded1.00
  • 1 Year change+14.21%
  • Beta0.6415
Data delayed at least 20 minutes, as of Feb 06 2026 14:28 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.

  • Revenue in EUR (TTM)1.29bn
  • Net income in EUR3.94m
  • Incorporated2016
  • Employees1.72k
  • Location
    H&R GmbH & Co KgaANeuenkirchener Str. 8SALZBERGEN 48499GermanyDEU
  • Phone+49 59769450
  • Fax+49 5 976945308
  • Websitehttps://www.hur.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.